Bourdon David 4
4 · LifeStance Health Group, Inc. · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
LifeStance (LFST) CEO David Bourdon Receives RSU/PSU Awards
What Happened David Bourdon, CEO of LifeStance Health Group (LFST), had equity awards vest on March 9, 2026. The Form 4 reports two award/acquisition entries totaling 328,544 shares (awarded at $0.00 per share as vested RSUs/PSUs). To satisfy tax withholding on the net settlement, the issuer withheld 148,382 shares at an implied price of $6.91 per share, with the withheld shares valued at about $1.03 million (reported totals: $75,208; $355,685; $594,426). The withheld shares are reductions of shares issued and are not open‑market sales.
Key Details
- Transaction date: March 9, 2026; Form 4 filed March 11, 2026 (filed within the normal two‑business‑day window).
- Awards acquired: 328,544 shares (two vested PSU/RSU grants).
- Shares withheld for taxes: 148,382 shares at $6.91/share, total withheld ≈ $1,025,319.
- Net shares issued to Bourdon after withholding: 180,162 shares (328,544 − 148,382).
- Transaction codes: A = Award/Grant (vesting); F = Tax withholding (not an open‑market sale).
- Footnotes explain these were performance‑based RSUs/PSUs that vested and that withheld shares “do not constitute any open‑market sale.”
Context This was a compensation/vesting event (performance‑based RSUs/PSUs vesting), not a purchase or voluntary sale. Net settlement via share withholding to cover taxes (a common practice) reduces the number of shares actually delivered to the insider and should not be read as a bearish sale. The filing appears timely and does not indicate a 10% owner or a 10b5‑1 plan.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-03-09$6.91/sh−10,884$75,208→ 1,207,201 total - Award
Common Stock
[F2]2026-03-09+122,994→ 1,330,195 total - Tax Payment
Common Stock
[F3]2026-03-09$6.91/sh−51,474$355,685→ 1,278,721 total - Award
Common Stock
[F4]2026-03-09+205,550→ 1,484,271 total - Tax Payment
Common Stock
[F5]2026-03-09$6.91/sh−86,024$594,426→ 1,398,247 total
Footnotes (5)
- [F1]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
- [F2]Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026.
- [F3]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
- [F4]Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026.
- [F5]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.